EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective

Naomi Scarano iD, Francesca Musumeci iD, Beatrice Casini, Chiara Brullo iD, Pasqualina D'Ursi iD, Paola Fossa iD, Silvia Schenone, Elena Cichero

International Journal of Molecular Sciences · 20.07.2025 · 26 (14) · 6980

DOI: 10.3390/ijms26146980 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.07.2025. Verfasst von Naomi Scarano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Section of Medicinal Chemistry, School of Medical and Pharmaceutical Sciences, University of Genoa, Viale Benedetto XV, 3, 16…. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 446 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Genoa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive, complex, multifactorial, neurodegenerative disease and accounts for most cases of dementia. The currently approved therapy includes cholinesterase inhibitors, NMDA-receptor antagonists and monoclonal antibodies. However, these medications were gradually discovered to be ineffective in removing the root of AD pathogenesis, having only symptomatic effects. Thus, the priority remains prevention and clarifying AD etiology. A better understanding of the neuroprotective mechanisms undertaken by specific genes is crucial to guide the design of novel therapeutic agents via selective ligands and precision medicine. In this review, we present a perspective of the physiological phase of the AD spectrum, of risk factors in AD with a focus on therapeutic approaches in three categories: neurotransmitters/ion modulations, peptide deposit control and aspecific treatments, followed by a discussion of treatment limitations. An overview of innovative strategies and non-pharmaceutical ancillary support is given.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansAnimalsNeuroprotective AgentsNeurotransmitter AgentsRisk FactorsCholinesterase Inhibitors

Stichwörter der Autor:innen

Alzheimer’s diseaseFDA approved drugsnon-pharmacological treatmentspreventionrisk factorstherapeutics strategies

Substanzen

Neuroprotective AgentsNeurotransmitter AgentsCholinesterase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy, Section of Medicinal Chemistry, School of Medical and Pharmaceutical Sciences, University of Genoa, Viale Benedetto XV, 3, 16132 Genoa, Italy.
  • Institute for Biomedical Technologies, National Research Council, 20054 Segrate, Milan, Italy.

ORCID-Profile: Naomi Scarano, Francesca Musumeci, Chiara Brullo, Pasqualina D'Ursi, Paola Fossa

Förderung

  • University of Genoa

Zitieren

APA

Scarano, N., Musumeci, F., Casini, B., Brullo, C., D'Ursi, P., Fossa, P., Schenone, S., & Cichero, E. (2025). Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective. International Journal of Molecular Sciences, 26(14), 6980. https://doi.org/10.3390/ijms26146980

Vancouver

Scarano N, Musumeci F, Casini B, Brullo C, D'Ursi P, Fossa P, et al. Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective. International Journal of Molecular Sciences. 2025;26(14):6980. doi:10.3390/ijms26146980

BibTeX
@article{Scarano2025,
  author = {Scarano, Naomi and Musumeci, Francesca and Casini, Beatrice and Brullo, Chiara and D'Ursi, Pasqualina and Fossa, Paola and Schenone, Silvia and Cichero, Elena},
  title = {Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {14},
  pages = {6980},
  doi = {10.3390/ijms26146980}
}
Kostenlos starten →